This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA138519; GEO: GSE27641 |
| Type | Umbrella project |
| Publications | Fuchs BC et al., "Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.", Hepatology, 2014 Apr;59(4):1577-90 |
| Submission | Registration date: 2-Mar-2011
University of Texas Southwestern Medical Center |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| GEO DataSets | 4 |
GEO Data Details| Parameter | Value |
|---|
| Data volume, Spots | 813697 |
| Data volume, Processed Mbytes | 21 |
| Data volume, Supplementary Mbytes | 4 |
EGFR inhibition prevents liver cirrhosis and hepatocellular carcinoma encompasses the following 3 sub-projects:
| Project Type | Number of Projects |
| Transcriptome or Gene expression | 3 |
BioProject
accession | Organism | Title |
|---|
| PRJNA141763 | Mus musculus | Gene expression profile of liver tissue in carbon tetrachloride (CCl4)-treated mouse treated with erlotinib (University of Texas Southwestern...) | | PRJNA141685 | Rattus norvegicus | Gene expression profile of liver tissue in low-dose, repeated diethylnitrosamine (DEN)-treated rat treated with erlotinib (Icahn School of Medicine...) | | PRJNA141761 | Rattus norvegicus | Gene expression profile of hepatocellular carcinoma in low-dose, repeated diethylnitrosamine (DEN)-treated rat treated with erlotinib (Icahn School of Medicine...) |
|